Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Ameri Hldn Wt 11.23
AMRHW

Buy AMRHW Stock

AMRHW
See AMRHW stock price and Buy/Sell Ameri Hldn Wt 11.23 with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.
AMRHW

Ameri Hldn Wt 11.23 (AMRHW)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Ameri Hldn Wt 11.23 (AMRHW)

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet me...Read more
Market Cap
1 Year High
Volume
1 Year Low
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch AMRHW stock

AMRHW stock rating

What analysts recommend for AMRHW stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell

AMRHW price target

What analysts think AMRHW will be worth
Low $0
High $0
Current $0
Target $0

Buy AMRHW Stock

AMRHW
See AMRHW stock price and Buy/Sell Ameri Hldn Wt 11.23 with any amount of money. Discuss news and analyst's price prediction with the investor community. Enter your cell phone number to get started.

Community

People who own or watch AMRHW stock
  • ceocrunchtime avatar
  • 2020phillip avatar
  • antdogg71 avatar
  • rmcall12 avatar
  • flyboiface avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency trading is provided by Apex Crypto LLC (“Apex Crypto”). Apex Crypto is not a registered broker-dealer or FINRA member and is not affiliated with Public Holdings or any of its subsidiaries. Cryptocurrencies are not securities and your cryptocurrency holdings are not FDIC or SIPC insured. Crypto trading involves a substantial risk of loss as there is significant volatility in the price of cryptocurrencies.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.